翔宇医疗(688626.SH)上半年净利润3539.47万元，同比下降37.5%

Group 1 - The core viewpoint of the article highlights that Xiangyu Medical (688626.SH) reported its mid-year results for 2025, showing a revenue of 359 million yuan, which represents a year-on-year growth of 6.27% [1] - The net profit attributable to shareholders of the parent company was 35.39 million yuan, reflecting a significant decline of 37.5% compared to the previous year [1] - The basic earnings per share (EPS) for the company stood at 0.23 yuan [1]